The Development and Current Use of BCL-2 Inhibitors for the Treatment of Chronic Lymphocytic Leukemia
Crossref DOI link: https://doi.org/10.1007/s11899-017-0359-0
Published Online: 2017-01-23
Published Print: 2017-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lampson, Benjamin L.
Davids, Matthew S.
License valid from 2017-01-23
